Pay in 4 interest-free payments of $5.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
glp 1 receptor drugs Chemical structures of GLP-1 antagonists. Representative CAS 2381089-83-2 Quantity:Full Case (12 Bottles) Retatrutide is a triple-agonist
Retatrutide is a triple-agonist drug targeting GLP-1, GIP, and glucagon receptors to suppress appetite and boost thermogenesis. Phase 2 trials reported 24.2% average weight loss and over 80% liver fat reduction, reversing
GLP-1R works through the combination of the endogenous ligand Glucagon-like peptide-1 (GLP-1) or exogenous agonists, which activate multiple intracellular signaling pathways that enhance insulin secretion, inhibit glucagon secretion, protect β-cells from apoptosis, delay gastric emptying and increase satiety
CAS 2381089-83-2
Quantity:Full Case (12 Bottles)
2020, pp
US$ 28.85
US$ 20.14
US$ 28.43
US$ 23.77